Dr. Wayne Hiroshi Fujita, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 99-128 Aiea Heights Dr, Suite 401, Aiea, HI 96701 Phone: 808-488-3000 Fax: 808-488-9025 |
Paul S Takiguchi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 550, Aiea, HI 96701 Phone: 808-487-0083 Fax: 808-488-4209 |
Dr. Jenifer C. Fong, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 98-151 Pali Momi St, Suite 152, Aiea, HI 96701 Phone: 808-483-6472 Fax: 808-483-6473 |
Mika L Yamazaki, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 95-151 Pali Momi Street, Aiea, HI 96701 Phone: 808-483-6400 |
News Archive
United States and Japanese researchers have identified a key step in metabolic pathways linked to diabetes and cancer. The study on activation of the protein complex TORC 2 was published online in the journal Current Biology Oct. 28.
"China's vaccine makers are gearing up over the next few years to push exports in a move that should lower costs of lifesaving immunizations for the world's poor and provide major new competition for the big Western pharmaceutical companies," the Associated Press reports in a feature examining the entry of Chinese vaccine makers into the international market.
Alimera Sciences Limited, the European subsidiary of Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced the availability of real world data from 28 injections of ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) in Europe, presented in a review paper authored by Fahd Quhill, Consultant Ophthalmologist, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, South Yorkshire, U.K.
At the opening ceremony of the XVIII International Congress for Tropical Medicines and Malaria (ICTMM) and the XLVIII Congress of the Brazilian Society of Tropical Medicine in Rio de Janeiro, the Ministry of Health of Brazil signed a Cooperation and Technical Assistance Agreement with the Oswaldo Cruz Foundation (FIOCRUZ) and the Drugs for Neglected Diseases initiative (DNDi) Latin America, uniting the three actors into a strategic partnership to collaborate on research and development (R&D) for new therapies and diagnostics for neglected diseases.
› Verified 2 days ago